Skin is more than a reflection in the mirror it’s the largest organ of your body, toiling away to shield you from the outside ...

Nektar Therapeutics said it would release topline data from a study of its atopic dermatitis treatment rezpegaldesleukin on Tuesday. Shares climbed 27% to $12.15 in after-hours trading Monday.

Shares of Nektar Therapeutics soared after the company said it would release topline data from a study of its atopic dermatitis treatment rezpegaldesleukin. The stock was up 31% at $12.49 in Monday's ...

Investing.com -- Nektar Therapeutics (NASDAQ: NKTR) stock surged 20% following the company’s announcement that it will present top-line data from its REZOLVE-AD Phase 2b clinical trial for atopic ...

On 16 June 2025, the Company announced that the board of directors had resolved on the Directed Issue I. Through the Directed Issue I, SciBase will receive proceeds of approximately SEK 19 million ...

The FDA pushed back the Prescription Drug User Fee Act action date for ruxolitinib cream (Opzelura) by three months to September 19, 2025. The extension will allow regulators time to review additional ...

A new study published in the Journal of American Medical Association showed that dupilumab (Dupixent), used for treating ...

A team led by the University of Exeter, and including researchers from King's College London, has been awarded a £3.3 million grant from the Medical ...

FDA extends review of Incyte's ruxolitinib cream for children with atopic dermatitis, delaying decision to September 2025.

Shea butter has historically been used for skin ailments for centuries. Learn the wide range of shea butter benefits and how ...

A team of researchers led by the University of Exeter have been awarded a £3.3 million grant by the Medical Research Council ...

A Board-Certified Dermatologist is urging people to eat one food and drink one drink for clear skin. Speaking on the 'A ...